Published on Nov 16, 2020
LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.
Occuity is developing non-contact diagnostic devices for disease screening and monitoring
The company’s intellectual property is being used to develop handheld pachymeters, keratometers, and pupillometers for use in human and veterinary optometry. According to Occuity, the device will be released in 2021. In October 2020, the company raised $1.3M in a Seed round. Alcon, Carl Zeiss, and Nidek are key strategics currently competing in the ophthalmology market.Path EX is using extracorporeal blood cleansing technology to treat sepsis
The Path EX device is being developed to diagnose and treat sepsis through the removal of pathogens and endotoxins from circulating blood. Pre-clinical studies have demonstrated that the device can reduce the concentration of pathogens by approximately 95% in a single pass of contaminated blood. In October 2020, Path EX received $100,000 for winning the Diamond Prize from MassChallenge. To-date, the company has raised approximately $740,000.
EKO raises $65M in Series C round
EKO develops and commercializes digital stethoscopes and stethoscope accessories. The company’s flagship device is the FDA cleared DUO ECG & Stethoscope, which combines an ECG and stethoscope into a single handheld device. In addition to their own stethoscopes, the company has partnered with 3M to integrate their CORE technology with 3M’s Littmann digital stethoscope. Following the completion of this recent fundraising round, the company has raised approximately $95.5M.
Razor Medical Instruments – optimizing patient safety and surgical outcomes in orthopedic surgery
The company is developing single-use instruments for use in large-joint replacement surgeries. Razor Medical Instruments recently completed a Seed round in which the company raised $700,000. Key strategics in the orthopedic surgery market include DePuy Synthes, Smith & Nephew, and Zimmer-Biomet.
StartBox is preventing wrong site surgery using its data-driven approach
The StartBox Patient Safety Solution pairs a surgical safety kit with a cloud-based system to prevent wrong site surgery and capture near misses in real-time. The system allows healthcare providers to flag errors in real-time to prevent wrong site surgery and costly medicolegal risks. To-date, the company has raised approximately $8.8M. Cardinal Health, Johnson & Johnson, and Stryker are some of the major competitors in this market.
X-Cor Therapeutics completes $2.6M Seed round
X-Cor Therapeutics is developing a novel CO2 device for the treatment of patients with hypercarbic respiratory failure, which can be triggered by chronic diseases such as cystic fibrosis or COPD, as well as respiratory infection and acute trauma. The company’s extracorporeal device is unique for its ultra-low-blood flow, which is more accessible, cost-effective, and safer than currently available technologies. Leading competitors in this market include ALung Technologies, Getinge Group, and Medica S.p.A.
Learn about the hottest venture funded startups developing innovative medical technologies using Life Science Intelligence’s Medtech Startup Tracker.
LSI's global events attract top innovators, active investors, and deal-making strategics.GET INFO